ICW Makes a Substantial Strategic Commitment to Focus on the U.S. Market

InterComponentWareInterComponentWare AG (ICW), an international eHealth company headquartered in Walldorf, Germany, has invested substantially over the last two years to strongly focus on the current and future needs of the U.S. healthcare market, especially in the areas of Care Coordination and Care Management. Based on its mature, best-of-breed Health Information Exchange (HIE) and Master Patient Index (MPI) solutions, ICW has developed care management applications supporting care pathways across all venues, as well as applications for collaborative care coordination. Due to its considerable progress, ICW has decided to reopen their operations in the U.S with teams in business development, sales and product management. ICW Inc. is headquartered in Bala Cynwyd, PA, includes key representatives in the Northeast and Silicon Valley, and is led by board members Peter J. Kirschbauer (Chairman & CEO), Nils Effertz (Chief Business Development Officer & COO) and Matthias Glück (Chief Financial Officer), along with top U.S. industry advisors.

"The U.S. Health Information Technology (HIT) market has made tremendous progress over the past years and its dynamics provide excellent opportunities for us. We're excited about supporting critical progress in underlying technologies, a plethora of care delivery applications, and multiple stakeholder collaborations within a U.S. healthcare system that is increasingly shifting from fee-for-service to fee-for-value. Our go-to-market strategy will be centered around key strategic partnerships, which, as part of sustainably growing our U.S. organization, we'll complement with select direct initiatives to work closely with our valued U.S. customers in order to meet their needs and gather best practices for IT adoption in healthcare ," says Nils Effertz.

ICW delivers solutions ideally suited for risk bearing healthcare organizations such as Accountable Care Organizations (ACO), as well as Integrated Delivery Networks (IDN), Health Systems and HIE focused organizations. ICW's products are offered both via one-time and subscription-based licensing, benefiting from 15 years of strong HIT software development expertise from its Germany-based parent company, ICW AG.

"This is a great time to partner and work with ICW. We're convinced that ICW is at the beginning of a U.S. growth cycle and we’ll be 100% focused on helping our partners and clients succeed in adopting HIT that is fully aligned with their strategic goals and gets us closer to achieving the triple aim of healthcare: better care, lower costs and improved outcomes. ICW's full commitment to the U.S. is fostered by our strong belief that a majority of our revenue will come from the U.S. market over the next years," states Peter J. Kirschbauer.

Related news articles:

About InterComponentWare AG
We are a privately owned international software company with over 15 years of experience in the field of Healthcare IT. We are headquartered in Walldorf, Germany, have our own subsidiary in the U.S. and are strongly U.S. market focused. We build efficient and reliable solutions to improve the quality and efficiency of care across the entire care continuum. Our solutions enable healthcare organizations to leverage innovative models for cross-enterprise care coordination and patient-centric care delivery. We apply state-of-the-art software technology to develop robust and highly scalable applications with a strong focus on optimal user experience. We support the most advanced communication and interoperability standards by design, and turn seamless integration into a straightforward process. Together with our partners, we deliver safe and sustainable solutions for more than 20 million patients across the United States, Germany and Switzerland.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...